raloxifene hydrochloride has been researched along with Innate Inflammatory Response in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Huang, J; Kang, F; Zou, Q | 1 |
| Chen, SY; Cheng, PY; Kung, CW; Lam, KK; Lee, YM; Shen, HH; Wu, HM; Yang, CY | 1 |
| Guo, J; Huo, S; Li, C; Li, S; Lin, J; Lin, L; Liu, T; Luo, P; Lv, J; Ma, H; Shi, W; Wang, M; Wang, Y; Yan, D; Zhang, C | 1 |
| Härkönen, P; Kangas, L; Linnanen, T; Määttä, J; Polari, L; Sousa, S; Wiklund, A | 1 |
| Ishida, A; Ishihara, Y; Itoh, K; Yamazaki, T | 1 |
| Abreu, GR; Bissoli, NS; Caliman, IF; Dalpiaz, PL; de Melo, AF; Gouvea, SA; Lamas, AZ; Lemos, EM | 1 |
| Jamdade, VS; Kumar, P; Lahkar, M; Mundhe, NA; Tadla, V | 1 |
| Coppola, A; Di Carlo, R; Esposito, E; Iacono, A; Meli, R; Pacilio, M; Raso, GM | 1 |
| Huuskonen, J; Nuutinen, T; Ojala, J; Salminen, A; Suuronen, T; Thornell, A | 1 |
| Boscaro, M; Camilletti, A; Francucci, CM | 1 |
| Asano, A; Kobayashi, J; Mabuchi, H; Muramoto, H; Murase, Y; Yamaaki, N; Yonezawa, K | 1 |
| Kluft, C | 1 |
| Eilertsen, AL; Sandset, PM; Sandvik, L; Steinsvik, B | 1 |
| Bryant, M; Clark, L; Garces, A; Rhodin, J; Thomas, T | 1 |
| Blum, A; Cannon, RO | 1 |
| Clarkson, TB; Mikkola, TS | 1 |
5 review(s) available for raloxifene hydrochloride and Innate Inflammatory Response
| Article | Year |
|---|---|
The effects of raloxifene on endothelial function and Inflammation in Postmenopausal women: A Meta-analysis of randomized controlled trials.
Topics: Biomarkers; Female; Humans; Inflammation; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic | 2022 |
Raloxifene and cardiovascular health: its relationship to lipid and glucose metabolism, hemostatic and inflammation factors and cardiovascular function in postmenopausal women.
Topics: Aged; Binding Sites; Cardiovascular System; Endothelium, Vascular; Female; Glucose; Hemostasis; Homocysteine; Humans; Inflammation; Lipid Metabolism; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Ventricular Function, Left | 2005 |
Effects of hormone treatment on hemostasis variables.
Topics: Administration, Oral; Administration, Topical; Dose-Response Relationship, Drug; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Hemostasis; Humans; Inflammation; Norpregnenes; Progestins; Raloxifene Hydrochloride; Tamoxifen; Venous Thromboembolism | 2007 |
Selective estrogen receptor modulator effects on serum lipoproteins and vascular function in postmenopausal women and in hypercholesterolemic men.
Topics: Animals; Disease Models, Animal; Female; Humans; Hypercholesterolemia; Inflammation; Lipoproteins; Male; Nitric Oxide; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2001 |
Estrogen replacement therapy, atherosclerosis, and vascular function.
Topics: Aged; Aging; Animals; Coronary Artery Disease; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Non-Steroidal; Female; Humans; Inflammation; Isoflavones; Lipids; Macaca; Male; Middle Aged; Models, Animal; Phytoestrogens; Plant Preparations; Progestins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators | 2002 |
1 trial(s) available for raloxifene hydrochloride and Innate Inflammatory Response
| Article | Year |
|---|---|
Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers.
Topics: Aged; Antineoplastic Agents, Hormonal; Biomarkers; Bone Density Conservation Agents; C-Reactive Protein; Cell Adhesion; Estrogen Replacement Therapy; Female; Humans; Inflammation; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride | 2008 |
11 other study(ies) available for raloxifene hydrochloride and Innate Inflammatory Response
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Raloxifene inhibits adipose tissue inflammation and adipogenesis through Wnt regulation in ovariectomized rats and 3 T3-L1 cells.
Topics: 3T3-L1 Cells; Adipogenesis; Adipose Tissue; Animals; Female; Gene Expression Regulation; Inflammation; Lipopolysaccharides; Mice; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Wnt Proteins; Wnt1 Protein | 2019 |
Raloxifene inhibits IL-6/STAT3 signaling pathway and protects against high-fat-induced atherosclerosis in ApoE
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cell Movement; Cell Survival; Cells, Cultured; Diet, High-Fat; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Interleukin-6; Male; Mice; Mice, Knockout; Plaque, Atherosclerotic; Raloxifene Hydrochloride; Rats; RAW 264.7 Cells; Signal Transduction; STAT3 Transcription Factor | 2020 |
SERMs Promote Anti-Inflammatory Signaling and Phenotype of CD14+ Cells.
Topics: Adult; Cell Line; Cell Line, Tumor; Cells, Cultured; Humans; Inflammation; Lipopolysaccharide Receptors; Macrophages; Middle Aged; NF-kappa B; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Signal Transduction; Th2 Cells; Young Adult | 2018 |
Selective estrogen-receptor modulators suppress microglial activation and neuronal cell death via an estrogen receptor-dependent pathway.
Topics: Animals; Cell Death; Cell Line, Tumor; Cell Survival; Culture Media, Conditioned; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; Fulvestrant; Inflammation; Male; Microglia; Neurons; Plasmids; Raloxifene Hydrochloride; Rats; Rats, Wistar; Receptors, Estrogen; Response Elements; Selective Estrogen Receptor Modulators; Tamoxifen | 2015 |
Comparative effects of estrogen, raloxifene and tamoxifen on endothelial dysfunction, inflammatory markers and oxidative stress in ovariectomized rats.
Topics: Acetylcholine; Animals; Anti-Inflammatory Agents; Cytokines; Endothelium, Vascular; Estrogen Antagonists; Estrogens; Female; Inflammation; NG-Nitroarginine Methyl Ester; Ovariectomy; Oxidative Stress; Postmenopause; Raloxifene Hydrochloride; Rats; Rats, Wistar; Reactive Oxygen Species; Tamoxifen; Vasodilation | 2015 |
Raloxifene Inhibits NF-kB Pathway and Potentiates Anti-Tumour Activity of Cisplatin with Simultaneous Reduction in its Nephrotoxictiy.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Cisplatin; Drug Synergism; Female; Inflammation; Kidney Diseases; Mammary Neoplasms, Animal; NF-kappa B; Raloxifene Hydrochloride; Rats; Rats, Wistar; Signal Transduction | 2016 |
Raloxifene, a selective estrogen receptor modulator, reduces carrageenan-induced acute inflammation in normal and ovariectomized rats.
Topics: Animals; Carrageenan; Edema; Estradiol; Female; Inflammation; Male; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Reference Values; Selective Estrogen Receptor Modulators | 2005 |
Anti-inflammatory effect of selective estrogen receptor modulators (SERMs) in microglial cells.
Topics: Animals; Anti-Inflammatory Agents; Astrocytes; Blotting, Northern; Cell Proliferation; Cells, Cultured; CpG Islands; DNA; Dose-Response Relationship, Drug; Down-Regulation; Enzyme-Linked Immunosorbent Assay; Estradiol; Fulvestrant; Hippocampus; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Inflammation; Interleukin-6; L-Lactate Dehydrogenase; Lipopolysaccharides; Mice; Microglia; Nitric Oxide; Oligonucleotides; Protein Binding; Raloxifene Hydrochloride; Rats; Rats, Wistar; RNA, Messenger; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors | 2005 |
Effects of raloxifene on adipocytokines in Japanese osteoporotic postmenopausal women with and without type 2 diabetes.
Topics: Adipose Tissue; Aged; Aged, 80 and over; Biomarkers; Body Fat Distribution; Bone Density Conservation Agents; Cytokines; Diabetes Mellitus, Type 2; Female; Humans; Inflammation; Japan; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride | 2006 |
Estrogen and raloxifene activities on amyloid-beta-induced inflammatory reaction.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Animals; Estrogen Antagonists; Estrogens; Female; Humans; Inflammation; Male; Menopause; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Sex Factors | 2001 |